← Back

Addiction

Topic spotlight
TopicNeuro

addiction

Discover seminars, jobs, and research tagged with addiction across Neuro.
50 curated items50 Seminars
Updated 3 months ago
50 items · addiction

Latest

50 results
SeminarNeuroscience

The basal ganglia and addiction

Yonatan M Kupchik & Michel Engeln
The Hebrew University of Jerusalem resp Centre national de la recherche scientifique (CNRS)
Sep 26, 2025
SeminarNeuroscienceRecording

Currents of Hope: how noninvasive brain stimulation is reshaping modern psychiatric care; Adapting to diversity: Integrating variability in brain structure and function into personalized / closed-loop non-invasive brain stimulation for substance use disorders

Colleen Hanlon, PhD & Ghazaleh Soleimani, PhD
Brainsway / University of Minnesota
Mar 28, 2024

In March we will focus on TMS and host Ghazaleh Soleimani and Colleen Hanlon. The talks will talk place on Thursday, March 28th at noon ET – please be aware that this means 5PM CET since Boston already switched to summer time! Ghazaleh Soleimani, PhD, is a postdoctoral fellow in Dr Hamed Ekhtiari’s lab at the University of Minnesota. She is also the executive director of the International Network of tES/TMS for Addiction Medicine (INTAM). She will discuss “Adapting to diversity: Integrating variability in brain structure and function into personalized / closed-loop non-invasive brain stimulation for substance use disorders”. Colleen Hanlon, PhD, currently serves as a Vice President of Medical Affairs for BrainsWay, a company specializing in medical devices for mental health, including TMS. Colleen previously worked at the Medical University of South Carolina and Wake Forest School of Medicine. She received the International Brain Stimulation Early Career Award in 2023. She will discuss “Currents of Hope: how noninvasive brain stimulation is reshaping modern psychiatric care”. As always, we will also get a glimpse at the “Person behind the science”. Please register va talks.stimulatingbrains.org to receive the (free) Zoom link, subscribe to our newsletter, or follow us on Twitter/X for further updates!

SeminarNeuroscience

Neuromodulation of subjective experience

Siri Leknes
University of Oslo
Nov 14, 2023

Many psychoactive substances are used with the aim of altering experience, e.g. as analgesics, antidepressants or antipsychotics. These drugs act on specific receptor systems in the brain, including the opioid, serotonergic and dopaminergic systems. In this talk, I will summarise human drug studies targeting opioid receptors and their role for human experience, with focus on the experience of pain, stress, mood, and social connection. Opioids are only indicated for analgesia, due to their potential to cause addiction. When these regulations occurred, other known effects were relegated to side effects. This may be the cause of the prevalent myth that opioids are the most potent painkillers, despite evidence from head-to-head trials, Cochrane reviews and network meta-analyses that opioids are not superior to non-opioid analgesics in the treatment of acute or chronic non-cancer pain. However, due to the variability and diversity of opioid effects across contexts and experiences, some people under some circumstances may indeed benefit from prolonged treatment. I will present data on individual differences in opioid effects due to participant sex and stress induction. Understanding the effects of these commonly used medications on other aspects of the human experience is important to ensure correct use and to prevent unnecessary pain and addiction risk.

SeminarNeuroscienceRecording

Targeting Maladaptive Emotional Memories to Treat Mental Health Disorders: Insights from Rodent Models

Amy Milton
Department of Psychology, University of Cambridge
May 9, 2023

Maladaptive emotional memories contribute to the persistence of numerous mental health disorders, including post-traumatic stress disorder (PTSD), drug addiction and obsessive-compulsive disorder (OCD). Using rodent behavioural models of the psychological processes relevant to these disorders, it is possible to identify potential treatment targets for the development of new therapies, including those based upon disrupting the reconsolidation of maladaptive emotional memories. Using examples from rodent models relevant to multiple mental health disorders, this talk will consider some of the opportunities and challenges that this approach provides.

SeminarNeuroscience

Basal Ganglia in addiction

David M Lovinger & Louise Adermark
National Institute on Alcohol, Abuse and Alcoholism NIH resp. University of Gothenburg
Apr 28, 2023
SeminarNeuroscienceRecording

Integrative Neuromodulation: from biomarker identification to optimizing neuromodulation

Valerie Voon
Department of Psychiatry, University of Cambridge
Mar 7, 2023

Why do we make decisions impulsively blinded in an emotionally rash moment? Or caught in the same repetitive suboptimal loop, avoiding fears or rushing headlong towards illusory rewards? These cognitive constructs underlying self-control and compulsive behaviours and their influence by emotion or incentives are relevant dimensionally across healthy individuals and hijacked across disorders of addiction, compulsivity and mood. My lab focuses on identifying theory-driven modifiable biomarkers focusing on these cognitive constructs with the ultimate goal to optimize and develop novel means of neuromodulation. Here I will provide a few examples of my group’s recent work to illustrate this approach. I describe a series of recent studies on intracranial physiology and acute stimulation focusing on risk taking and emotional processing. This talk highlights the subthalamic nucleus, a common target for deep brain stimulation for Parkinson’s disease and obsessive-compulsive disorder. I further describe recent translational work in non-invasive neuromodulation. Together these examples illustrate the approach of the lab highlighting modifiable biomarkers and optimizing neuromodulation.

SeminarNeuroscienceRecording

How can we treat visceral pain?

David Bulmer
Department of Pharmacology, University of Cambridge
Nov 29, 2022

Chronic pain is a leading cause of morbidity, common to patients with gastrointestinal diseases such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Most pain killers are largely ineffective against this type of pain or restricted for use in these patients due to gut related complications and risk of addition. A significant unmet clinical need therefore exists to develop novel non-opioid based visceral analgesics.

SeminarNeuroscienceRecording

Sex Differences in Learning from Exploration

Cathy Chen
Grissom lab, University of Minnesota
Jun 8, 2022

Sex-based modulation of cognitive processes could set the stage for individual differences in vulnerability to neuropsychiatric disorders. While value-based decision making processes in particular have been proposed to be influenced by sex differences, the overall correct performance in decision making tasks often show variable or minimal differences across sexes. Computational tools allow us to uncover latent variables that define different decision making approaches, even in animals with similar correct performance. Here, we quantify sex differences in mice in the latent variables underlying behavior in a classic value-based decision making task: a restless two-armed bandit. While male and female mice had similar accuracy, they achieved this performance via different patterns of exploration. Male mice tended to make more exploratory choices overall, largely because they appeared to get ‘stuck’ in exploration once they had started. Female mice tended to explore less but learned more quickly during exploration. Together, these results suggest that sex exerts stronger influences on decision making during periods of learning and exploration than during stable choices. Exploration during decision making is altered in people diagnosed with addictions, depression, and neurodevelopmental disabilities, pinpointing the neural mechanisms of exploration as a highly translational avenue for conferring sex-modulated vulnerability to neuropsychiatric diagnoses.

SeminarNeuroscience

Cell type-specific gene regulatory mechanisms associated with addiction-related behaviors in rats

Francesca Telese, PhD
University of California, San Diego
May 11, 2022

Understanding the fundamental gene regulatory mechanisms underlying addiction and related behaviors could facilitate more effective treatments. We discuss our work using multi-omics methods to provide mechanistic and functional insights into how addiction perturbs gene regulatory programs in the rat brain, with single-cell resolution.

SeminarNeuroscienceRecording

Brain and behavioural impacts of early life adversity

Jeff Dalley
Department of Psychology, University of Cambridge
Apr 26, 2022

Abuse, neglect, and other forms of uncontrollable stress during childhood and early adolescence can lead to adverse outcomes later in life, including especially perturbations in the regulation of mood and emotional states, and specifically anxiety disorders and depression. However, stress experiences vary from one individual to the next, meaning that causal relationships and mechanistic accounts are often difficult to establish in humans. This interdisciplinary talk considers the value of research in experimental animals where stressor experiences can be tightly controlled and detailed investigations of molecular, cellular, and circuit-level mechanisms can be carried out. The talk will focus on the widely used repeated maternal separation procedure in rats where rat offspring are repeatedly separated from maternal care during early postnatal life. This early life stress has remarkably persistent effects on behaviour with a general recognition that maternally-deprived animals are susceptible to depressive-like phenotypes. The validity of this conclusion will be critically appraised with convergent insights from a recent longitudinal study in maternally separated rats involving translational brain imaging, transcriptomics, and behavioural assessment.

SeminarNeuroscience

Neuromodulation of sleep integrity

Luís de Lecea
Stanford University
Apr 12, 2022

The arousal construct underlies a spectrum of behaviors that include sleep, exploration, feeding, sexual activity and adaptive stress. Pathological arousal conditions include stress, anxiety disorders, and addiction. The dynamics between arousal state transitions are modulated by norepinephrine neurons in the locus coeruleus, histaminergic neurons in the hypothalamus, dopaminergic neurons in the mesencephalon and cholinergic neurons in the basal forebrain. The hypocretin/orexin system in the lateral hypothalamus I will also present a new mechanism underlying sleep fragmentation during aging. Hcrt neurons are hyperexcitable in aged mice. We identify a potassium conductance known as the M-current, as a critical player in maintaining excitability of Hcrt neurons. Genetic disruption of KCNQ channels in Hcrt neurons of young animals results in sleep fragmentation. In contrast, treatment of aged animals with a KCNQ channel opener restores sleep/wake architecture. These data point to multiple circuits modulating sleep integrity across lifespan.

SeminarNeuroscience

The neuroscience of lifestyle interventions for mental health: the BrainPark approach

Rebecca Segrave and Chao Suo
Monash University
Mar 16, 2022

Our everyday behaviours, such as physical activity, sleep, diet, meditation, and social connections, have a potent impact on our mental health and the health of our brain. BrainPark is working to harness this power by developing lifestyle-based interventions for mental health and investigating how they do and don’t change the brain, and for whom they are most effective. In this webinar, Dr Rebecca Segrave and Dr Chao Suo will discuss BrainPark’s approach to developing lifestyle-based interventions to help people get better control of compulsive behaviours, and the multi-modality neuroimaging approaches they take to investigating outcomes. The webinar will explore two current BrainPark trials: 1. Conquering Compulsions - investigating the capacity of physical exercise and meditation to alter reward processing and help people get better control of a wide range of unhelpful habits, from drinking to eating to cleaning. 2. The Brain Exercise Addiction Trial (BEAT) - an NHMRC funded investigation into the capacity of physical exercise to reverse the brain harms caused by long-term heavy cannabis use. Dr Rebecca Segrave is Deputy Director and Head of Interventions Research at BrainPark, the David Winston Turner Senior Research Fellow within the Turner Institute for Brain and Mental Health, and an AHRPA registered Clinical Neuropsychologist. Dr Chao Suo is Head of Technology and Neuroimaging at BrainPark and a Research Fellow within the Turner Institute for Brain and Mental Health.

SeminarNeuroscience

Stress deceleration theory: chronic adolescent stress exposure results in decelerated neurobehavioral maturation

Kshitij Jadhav
University of Cambridge
Jan 19, 2022

Normative development in adolescence indicates that the prefrontal cortex is still under development thereby unable to exert efficient top-down inhibitory control on subcortical regions such as the basolateral amygdala and the nucleus accumbens. This imbalance in the developmental trajectory between cortical and subcortical regions is implicated in expression of the prototypical impulsive, compulsive, reward seeking and risk-taking adolescent behavior. Here we demonstrate that a chronic mild unpredictable stress procedure during adolescence in male Wistar rats arrests the normal behavioral maturation such that they continue to express adolescent-like impulsive, hyperactive, and compulsive behaviors into late adulthood. This arrest in behavioral maturation is associated with the hypoexcitability of prelimbic cortex (PLC) pyramidal neurons and reduced PLC-mediated synaptic glutamatergic control of BLA and nucleus accumbens core (NAcC) neurons that lasts late into adulthood. At the same time stress exposure in adolescence results in the hyperexcitability of the BLA pyramidal neurons sending stronger glutamatergic projections to the NAcC. Chemogenetic reversal of the PLC hypoexcitability decreased compulsivity and improved the expression of goal-directed behavior in rats exposed to stress during adolescence, suggesting a causal role for PLC hypoexcitability in this stress-induced arrested behavioral development. (https://www.biorxiv.org/content/10.1101/2021.11.21.469381v1.abstract)

SeminarNeuroscienceRecording

Determinants of the transition to compulsion in addiction

Christian Lüscher
University of Geneva
Dec 16, 2021
SeminarNeuroscienceRecording

Linking valence and anxiety in a mouse insula-amygdala circuit

Anna Beyeler
University of Bordeaux
Dec 2, 2021
SeminarNeuroscienceRecording

Promising Neuroimmune Targets for Alcohol Use Disorder Pathology

Leon Coleman
UNC
Nov 18, 2021
SeminarNeuroscienceRecording

Nr4a1 and chromatin bivalency in cocaine pathophysiology

Liz Heller
University of Pennsylvania
Nov 11, 2021
SeminarNeuroscienceRecording

Sex Differences in Addiction: lessons from animal models

Jill Becker
University of Michigan
Oct 21, 2021
SeminarNeuroscienceRecording

Transcriptional and Epigenetic Mechanisms of Addiction

Eric Nestler
Mount Sinai
Oct 7, 2021
SeminarNeuroscienceRecording

The mu opioid receptor and addiction

Brigitte Kieffer
Inserm, Strasbourg
Sep 23, 2021
SeminarNeuroscienceRecording

In-Love with Addiction Neuroscience

Yasmin Hurd
Icahn School of Medicine at Mount Sinai, USA
Jul 15, 2021

In this talk series, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field. We hope that this talk series would encourage and support a new generation of young and passionate addiction neuroscientists in different countries to revolutionize the field of addiction medicine.

SeminarNeuroscienceRecording

How do I know my rat is addicted?

Véronique Deroche-Gamonet
Bordeaux Neurocampus
Jun 24, 2021
SeminarNeuroscienceRecording

D1 and D2 Accumbens Neurons May not be Who You Think They Are:  Distinct tetrapartite synaptic plasticity regulating drug relapse

Peter Kalivas
Medical University of South Carolina
Jun 17, 2021
SeminarNeuroscienceRecording

Neuroimmune and Glutamatergic Mechanisms of Nicotine Addiction

Cassandra Gipson-Reichardt
University of Kentucky
Jun 10, 2021
SeminarNeuroscienceRecording

In-Love with Addiction Neuroscience

Min Zhao
Shanghai Jiao Tong University, China
Jun 10, 2021

In this talk series, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field. We hope that this talk series would encourage and support a new generation of young and passionate addiction neuroscientists in different countries to revolutionize the field of addiction medicine.

SeminarNeuroscienceRecording

Habenular synaptic strength and neuronal dynamics for approach-avoidance behaviours

Manuel Mameli
University of Lausanne
Jun 3, 2021
SeminarNeuroscienceRecording

Acetylcholine dynamics in the basolateral amygdala during reward learning

Marina Picciotto
Yale School of Medicine
May 27, 2021
SeminarNeuroscienceRecording

Ready, Set, Go! Neural circuits underlying cognitive control of behavior

Huib Mansvelder
VU University Amsterdam
May 20, 2021
SeminarNeuroscienceRecording

Mitochondrial mechanisms in psychostimulant and opioid action

Mary Kay Lobo
University of Maryland
May 13, 2021
SeminarNeuroscienceRecording

In-Love with Addiction Neuroscience

Anne Lingford-Hughes
Imperial College London, UK
May 13, 2021

In this talk series, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field. We hope that this talk series would encourage and support a new generation of young and passionate addiction neuroscientists in different countries to revolutionize the field of addiction medicine.

SeminarNeuroscienceRecording

Dopamine release in the nucleus accumbens core signals perceived saliency

Erin Calipari
Vanderbilt University
May 6, 2021
SeminarNeuroscienceRecording

Addiction to cocaine: How you take the drug is more important than how much

Anna Samaha
Université de Montréal
Apr 29, 2021
SeminarNeuroscienceRecording

Addiction: the compulsive pursuit of a behaviour, not only the drug

David Belin
University of Cambridge
Apr 22, 2021
SeminarNeuroscienceRecording

New genetically encoded sensors to track addiction-relevant neuromodulators in vivo

Tommaso Patriarchi
University of Zurich
Apr 15, 2021
SeminarNeuroscienceRecording

Striatal mechanisms underlying vulnerability for punishment-resistant alcohol drinking

Veronica Alvarez
NIH
Apr 8, 2021
SeminarNeuroscienceRecording

In-Love with Addiction Neuroscience

Kathleen Brady
Medical University of South Carolina, USA
Apr 8, 2021

In this talk series, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field. We hope that this talk series would encourage and support a new generation of young and passionate addiction neuroscientists in different countries to revolutionize the field of addiction medicine.

SeminarNeuroscienceRecording

Pharmacokinetics trumps pharmacodynamics during drug reward valuation

Serge Ahmed
CNRS Université de Bordeaux
Apr 1, 2021
SeminarNeuroscienceRecording

Dopamine and relapse to drug seeking

Gavan McNally
UNSW Sydney
Mar 25, 2021
SeminarNeuroscienceRecording

Keeping the balance: a role for the insular cortex in emotion homeostasis

Nadine Gogolla
Max Planck Institute
Mar 18, 2021
SeminarNeuroscienceRecording

Non-canonical ventral pallidal circuits and their relevance for treating addiction

Meaghan Creed
Washington University School of Medicine, St-Louis
Mar 11, 2021
SeminarNeuroscienceRecording

In-Love with Addiction Neuroscience

Marc Potenza
Yale School of Medicine, USA
Mar 11, 2021

In this talk series, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field. We hope that this talk series would encourage and support a new generation of young and passionate addiction neuroscientists in different countries to revolutionize the field of addiction medicine.

SeminarNeuroscience

The anterior insular cortex in the rat exerts an inhibitory influence over the loss of control of heroin intake and subsequent propensity to relapse

Dhaval Joshi
University of Cambridge, Department of Psychology
Mar 3, 2021

The anterior insular cortex (AIC) has been implicated in addictive behaviour, including the loss of control over drug intake, craving and the propensity to relapse. Evidence suggests that the influence of the AIC on drug-related behaviours is complex as in rats exposed to extended access to cocaine self-administration, the AIC was shown to exert a state-dependent, bidirectional influence on the development and expression of loss of control over drug intake, facilitating the latter but impairing the former. However, it is unclear whether this influence of the AIC is confined to stimulant drugs that have marked peripheral sympathomimetic and anxiogenic effects or whether it extends to other addictive drugs, such as opiates, that lack overt acute aversive peripheral effects. We investigated in outbred rats the effects of bilateral excitotoxic lesions of AIC induced both prior to or after long-term exposure to extended access heroin self-administration, on the development and maintenance of escalated heroin intake and the subsequent vulnerability to relapse following abstinence. Compared to sham surgeries, pre-exposure AIC lesions had no effect on the development of loss of control over heroin intake, but lesions made after a history of escalated heroin intake potentiated escalation and also enhanced responding at relapse. These data show that the AIC inhibits or limits the loss of control over heroin intake and propensity to relapse, in marked contrast to its influence on the loss of control over cocaine intake.

SeminarNeuroscienceRecording

In-Love with Addiction Neuroscience

Silvia Cruz
The Center for Research and Advanced Studies (CINVESTAV), Mexico
Feb 11, 2021

In this talk series, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field. We hope that this talk series would encourage and support a new generation of young and passionate addiction neuroscientists in different countries to revolutionize the field of addiction medicine.

SeminarNeuroscience

A multiscale approach to brain disorders

Sean Hill
University of Toronto & Krembil Centre for Neuroinformatics at the Centre for Addiction and Mental Health (CAMH)
Jan 28, 2021
SeminarNeuroscienceRecording

Schizophrenia and Substance Use Disorders: Cracking the Chicken-or-Egg Question

Jibran Khokhar
Department of Biomedical Sciences University of Guelph
Jan 18, 2021

Although substance use disorders (SUDs) occur commonly in patients with schizophrenia and significantly worsen their clinical course, the neurobiological basis of SUDs in schizophrenia is not well understood. Therefore, there is a critical need to understand the mechanisms underlying SUDs in schizophrenia in order to identify potential targets for therapeutic intervention. Since drug use usually begins in adolescence, it is also important to understand the long-term effects of adolescent drug exposure on schizophrenia- and reward- related behaviors and circuitry. This talk will combine pharmacological, behavioral, electrophysiologic (local field potential recordings) and pre-clinical magnetic resonance imaging (resting-state functional connectivity and magnetic resonance spectroscopy) approaches to study these topics with an eye toward developing better treatment approaches.

SeminarNeuroscienceRecording

In-Love with Addiction Neuroscience

Antonio Verdejo-García
Monash Univesity, Australia
Dec 17, 2020

In this talk series, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field. We hope that this talk series would encourage and support a new generation of young and passionate addiction neuroscientists in different countries to revolutionize the field of addiction medicine.

SeminarNeuroscience

Neuronal encoding of drug choices and preference in the orbitofrontal cortex

Karine Guillem
CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France
Dec 11, 2020

Human neuroimaging research has consistently shown that drug addiction is associated with structural and functional changes within the orbitofrontal cortex (OFC). In view of the important role of the OFC in value-based decision-making, these changes have been hypothesised to bias choice towards drug use despite and at the expense of other competing pursuits, thereby explaining drug addiction. Here I will present in vivo recording data in the OFC supporting this hypothesis in a choice-based model of addiction where rats could choose between two actions, one rewarded by a drug (cocaine or heroin), the other by a nondrug alternative (saccharin).

SeminarNeuroscienceRecording

Social deprivation, coping and drugs: a bad cocktail in the COVID-19 era: evidence from preclinical studies

David Belin
Department of Psychology, University of Cambridge
Dec 8, 2020

The factors that underlie an individual’s vulnerability to switch from controlled, recreational drug use to addiction are not well understood. I will discuss the evidence in rats that in individuals housed in enriched conditions, the experience of drugs in the relative social and sensory impoverishment of the drug taking context, and the associated change in behavioural traits of resilience to addiction, exacerbate the vulnerability to develop compulsive drug intake. I will further discuss the importance of the acquisition of alcohol drinking as a mechanism to cope with distress as a factor of exacerbated vulnerability to develop compulsive alcohol intake. Together these results demonstrate that experiential factors in the drug taking context, which can be substantially driven by social isolation, shape the vulnerability to addiction.

addiction coverage

50 items

Seminar50
Domain spotlight

Explore how addiction research is advancing inside Neuro.

Visit domain